Peter Reynolds
Direttore Finanziario/CFO presso AEON Biopharma Sub, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Robert Palmisano | M | 79 |
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 anni |
| Eric Carter | M | 72 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 anni |
| Shelley Thunen | F | 71 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 anni |
| Chad Oh | M | 66 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 3 anni |
| Richard Taketa | M | 52 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 6 anni |
| Melinda Day | F | 64 |
Boy Scouts of America (Orange County Council)
 Boy Scouts of America (Orange County Council) Services to the Health IndustryHealth Services Part of Boy Scouts of America, Boy Scouts of America (Orange County Council) provides support services to youth and families. The company is based in Santa Ana, CA. | 13 anni |
| Chris Carr | M | 54 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 5 anni |
| Darren O Brien | M | 48 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 anni |
| Vikram Malik | M | 61 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 10 anni |
| Terry Scot Adams | M | 63 |
Boy Scouts of America (Orange County Council)
Boy Scouts of America (Orange County Council) Services to the Health IndustryHealth Services Part of Boy Scouts of America, Boy Scouts of America (Orange County Council) provides support services to youth and families. The company is based in Santa Ana, CA. | - |
| William Lyon | M | 50 |
Boy Scouts of America (Orange County Council)
Boy Scouts of America (Orange County Council) Services to the Health IndustryHealth Services Part of Boy Scouts of America, Boy Scouts of America (Orange County Council) provides support services to youth and families. The company is based in Santa Ana, CA. | - |
| Wayne J. Stelmar | M | 69 |
Boy Scouts of America (Orange County Council)
Boy Scouts of America (Orange County Council) Services to the Health IndustryHealth Services Part of Boy Scouts of America, Boy Scouts of America (Orange County Council) provides support services to youth and families. The company is based in Santa Ana, CA. | - |
| Adelbert L. Stagg | M | 77 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 5 anni |
| Debra L. Morris | F | 65 | 11 anni | |
| Simone Blank | F | 61 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 anni |
| Jost Fischer | M | 69 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 7 anni |
| Ed Inal | M | - |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 2 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Daniel Starck | M | 57 | 11 anni | |
| Mahvash Yazdi | F | 73 | 2 anni | |
| Jeff Ingram | M | - | - | |
| Mike Ruberio | M | - | 7 anni | |
| Jack Baikie | M | - | - | |
| Mark Litkovitz | M | - | 14 anni | |
| Douglas E. Rutledge | M | - | - | |
| Dan Kelly | M | - | - | |
| James G. Gallas | M | - | - | |
| Patrick J. Bourke | M | - | - | |
| Bradley R. Kreick | M | - | - | |
| Howard Derman | M | - | - | |
| Terry Bayer | F | 74 | 2 anni | |
| I. T. Corley | M | 79 | 5 anni | |
| Mike Zafirovski | M | 70 | 11 anni | |
| Vicente J. Anido | M | 71 | 6 anni | |
| Philip Lochner | M | 80 | 10 anni | |
| Richard Koppes | M | 77 | 10 anni | |
| Lawrence M. Higby | M | 78 | 11 anni | |
| David L. Goldsmith | M | 75 | 21 anni | |
| Harriet B. Albery | F | - | 1 anni | |
| Chris Karkenny | M | 55 | 6 anni | |
| Daniel E. Greenleaf | M | 59 | 2 anni | |
| Deb Crimmins | F | - | 3 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 41 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Peter Reynolds
- Contatti personali